Australia - English - Department of Health (Therapeutic Goods Administration)

medical & optical instruments australia pty ltd - 34003 - fixation device, internal, hip, plate, compression - the hansson pinloc 2 is an implant system intended for temporary stabilization of femoral neck fractures in adults until bone consolidation has been achieved. the implants are single use devices made of titanium alloy and sterile. the implants consist of hook pins and plates available in different sizes. the fully assembled hansson pinloc 2 implant consists of 3 hook pins locked into the chosen plate. when fully assembled, the hansson pinloc 2 implant becomes one unit.

Canada - English - Health Canada

mantra pharma inc - pilocarpine hydrochloride - tablet - 5mg - pilocarpine hydrochloride 5mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

sterimax inc - pilocarpine hydrochloride - tablet - 5mg - pilocarpine hydrochloride 5mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

methapharm inc - pilocarpine hydrochloride - tablet - 5mg - pilocarpine hydrochloride 5mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

jamp pharma corporation - pilocarpine hydrochloride - tablet - 5mg - pilocarpine hydrochloride 5mg - parasympathomemetic (cholinergic) agents

New Zealand - English - Medsafe (Medicines Safety Authority)

specialised therapeutics limited - ripretinib 50mg - tablet - 50 mg - active: ripretinib 50mg excipient: colloidal silicon dioxide crospovidone hypromellose acetate succinate lactose monohydrate magnesium stearate microcrystalline cellulose - qinlock is a kinase inhibitor indicated for the treatment of adult patients with advanced gastrointestinal stromal tumours (gist) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.

Israel - English - Ministry of Health

medison pharma ltd - ripretinib - tablets - ripretinib 50 mg - ripretinib - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (gist) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 5 mg - pilocarpine hydrochloride tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren's syndrome. pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.

United States - English - NLM (National Library of Medicine)

marlex pharmaceuticals inc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 5 mg - pilocarpine hydrochloride tablets, usp are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren’s syndrome. pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.

United States - English - NLM (National Library of Medicine)

lannett company, inc. - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 5 mg - pilocarpine hydrochloride tablets, usp are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren's syndrome. pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.